Orris

Patient known CKD, k 6.1 in bloods and on vbg 5.5 what do I do treat ?

Reading File
Finding Sources
Finding Sources
Searching PubMed

hyperkalemia AND treatment

Searching the Web

UK Kidney Association hyperkalaemia guideline serum potassium 6.0 ECG treatment 2023

Treat this as possible moderate hyperkalaemia until clarified. In a CKD patient, a laboratory K⁺ of 6.1 mmol/L warrants urgent assessment even if the VBG reads 5.5. The difference may reflect sampling or analyser variation, including haemolysis, but do not dismiss the higher laboratory result without checking.
  1. Assess immediately: observations, symptoms (weakness, palpitations, syncope), IV access, and an urgent 12-lead ECG. UK Kidney Association guidance recommends an urgent ECG for K⁺ ≥6.0 mmol/L. Put on continuous monitoring if there are ECG changes, clinical instability, a suspected rapid rise, or K⁺ reaches ≥6.5. See the UKKA hyperkalaemia guideline.
  2. Repeat urgently: send a fresh, non-haemolysed venous sample to the lab for U&E/plasma potassium, plus glucose, bicarbonate, creatinine and consider magnesium. Check the lab’s haemolysis flag. Review the VBG pH/HCO₃⁻, as acidosis increases urgency. Do this in parallel, not instead of ECG assessment/treatment.
  3. If ECG changes compatible with hyperkalaemia, arrhythmia, or the patient is unstable: activate your local emergency hyperkalaemia protocol now.
    • Give IV calcium to stabilise the myocardium. It protects the heart but does not lower K⁺.
    • Give potassium-shifting treatment, usually IV soluble insulin with glucose and nebulised salbutamol. Check capillary glucose before and frequently afterwards because delayed hypoglycaemia is common in CKD.
    • Consider bicarbonate only if there is significant metabolic acidosis, according to local guidance.
    • Escalate urgently to senior/renal/critical-care support.
  4. If ECG is normal and they are clinically well: K⁺ 6.1 is still not a “wait and see” result in CKD. While the repeat is pending:
    • Stop potassium supplements and potassium-containing fluids.
    • Hold contributing drugs where clinically appropriate: ACE inhibitor/ARB, spironolactone/eplerenone, amiloride, trimethoprim, NSAIDs, etc.
    • Check urine output, AKI, constipation, dietary intake, missed dialysis or access problems.
    • Discuss early with renal team if persistent/rising K⁺, oliguria, severe acidosis, fluid overload, or dialysis may be required.
  5. Definitive removal: potassium binders and/or loop diuretic may have a role depending on volume status and local protocol, but they are not substitutes for cardiac stabilisation/rapid shifting when there is ECG toxicity. Arrange urgent dialysis if potassium is refractory or there are other dialysis indications.
Bottom line: obtain ECG and repeat formal potassium urgently. With CKD and a verified serum K⁺ of 6.1, I would involve the responsible senior/renal team and use your hospital acute hyperkalaemia pathway. Give emergency treatment immediately if ECG changes or clinical deterioration are present.

Is it okay to give dex insulin in this kind of patient while we await repeat lab value as lab report will take time to come please 4-5 hrs

Reading File
Finding Sources
Finding Sources
Searching PubMed

hyperkalemia AND insulin AND hypoglycemia

Searching the Web

UKKA 2023 hyperkalaemia guideline insulin glucose potassium 6.0 6.4 treatment hypoglycaemia monitoring

Do not wait 4-5 hours for a routine lab result. Escalate to the senior/medical registrar and ask the laboratory for an urgent potassium or obtain a repeat point-of-care blood gas from a clean venous sample. Get an immediate 12-lead ECG and assess clinical status.
If the 6.1 mmol/L lab potassium is credible (not haemolysed, appropriate sample) then this meets moderate hyperkalaemia. The UKKA guideline says insulin-glucose may be used at K⁺ 6.0-6.4 mmol/L, and is recommended at ≥6.5 mmol/L. See the UKKA acute hyperkalaemia guidance.
However, with a simultaneous VBG K⁺ 5.5, it is not automatically right to give insulin/dextrose solely because the formal value is delayed. In CKD, insulin clearance is reduced and delayed, sometimes prolonged hypoglycaemia is a real risk. Treat now if any of the following apply:
  • ECG changes consistent with hyperkalaemia, arrhythmia, or clinical instability
  • convincing non-haemolysed K⁺ 6.1 with high-risk context: rising K⁺, oliguria/AKI, severe acidosis, missed dialysis, tissue breakdown
  • repeat point-of-care potassium is ≥6.0 or rising
If ECG is normal, the person is well, and you have only discordant K⁺ results (lab 6.1 vs VBG 5.5), the safer immediate action is urgent confirmation plus close monitoring and senior decision-making, rather than treating a possibly spurious result blindly.
If your senior/local acute hyperkalaemia protocol decides to treat:
  • Draw the repeat potassium first if possible, but do not delay emergency treatment for ECG toxicity.
  • Use the prescribed insulin-glucose regimen in your local protocol. UKKA uses soluble insulin 10 units with 25 g glucose IV for moderate/severe hyperkalaemia.
  • Check capillary glucose before treatment and monitor frequently for at least 6 hours. UKKA recommends additional 10% glucose infusion when pre-treatment glucose is <7 mmol/L.
  • Put the patient on cardiac monitoring if unwell, ECG abnormal, or K⁺ is rising.
  • Remember: insulin shifts potassium intracellularly temporarily. It does not remove potassium. Address cause and obtain renal input, especially with CKD/oliguria or dialysis dependence.
  • Give IV calcium first if ECG changes are present. Calcium stabilises the myocardium but does not lower potassium.
Also stop potassium-containing fluids/supplements and review potassium-raising drugs while this is being sorted.
This is a shared conversation. Sign in to Orris to start your own chat.